Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The pharmacokinetics and disposition of MK-0524, a Prosglandin D2 Receptor 1 antagonist, in rats, dogs and monkeys.
Xenobiotica; the fate of foreign compounds in biological systems·2007
Say Yes First: follow up of a five-year rural drug prevention program.
Journal of drug education·2004
Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs.
Journal of medicinal chemistry·2000
Substance P receptor antagonist I: conversion of phosphoramidate prodrug after i.v. administration to rats and dogs.
Drug metabolism and disposition: the biological fate of chemicals·1999
Hydroxamic acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.
Journal of medicinal chemistry·1996
Inhibition of antibacterial activity of himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus, by fatty acid sodium salts.
Antimicrobial agents and chemotherapy·1994
Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.
CPT: pharmacometrics & systems pharmacology·2026
The Future of all-Comers Trials in the Era of Precision Oncology.
Clinical pharmacology and therapeutics·2026
MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.
The Biochemical journal·2026
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
Journal of Alzheimer's disease : JAD·2026
Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.
Current pharmaceutical design·2026